Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma.
Munshi
Nikhil C
NC
Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA. nikhil_munshi@dfci.harvard.edu
Mitsiades
Constantine
C
Richardson
Paul G
PG
Anderson
Kenneth C
KC